Literature DB >> 24231381

Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6')-Ib.

Bjørg C Haldorsen1, Gunnar Skov Simonsen2, Arnfinn Sundsfjord2, Orjan Samuelsen3.   

Abstract

In this study, we show that the increasing prevalence of aminoglycoside resistance observed in Norway among clinical Escherichia coli and Klebsiella spp. isolates is mainly due to the presence of the aminoglycoside-modifying enzymes AAC(3)-II and AAC(6')-Ib. A frequent co-association of aminoglycoside resistance with Cefotaximase-München group 1 extended-spectrum β-lactamases was also observed.
© 2013.

Entities:  

Keywords:  AAC(3)-II; AAC(6′)-Ib; CTX-M; ESBL; RmtB

Mesh：

Substances：

Year:  2013        PMID： 24231381     DOI： 10.1016/j.diagmicrobio.2013.10.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  14 in total

Review 1.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for the Rapid Detection of Antimicrobial Resistance Mechanisms and Beyond.

Authors:  Marina Oviaño; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

2.  Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?

Authors:  Cristina García-Salguero; Iciar Rodríguez-Avial; Juan J Picazo; Esther Culebras
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.

Authors:  Maria Del Carmen López-Diaz; Esther Culebras; Iciar Rodríguez-Avial; Esther Rios; José Manuel Viñuela-Prieto; Juan J Picazo; Carmen Rodríguez-Avial
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain.

Authors:  Marta Fernández-Martínez; Belén Ruiz Del Castillo; Maria Jesús Lecea-Cuello; Jesús Rodríguez-Baño; Álvaro Pascual; Luis Martínez-Martínez
Journal:  Microb Drug Resist       Date:  2017-10-03       Impact factor: 3.431

5.  Prevalence of carbapenemases among high-level aminoglycoside-resistant Acinetobacter baumannii isolates in a university hospital in China.

Authors:  Yanhong Wang; Min Shen; Jingni Yang; Min Dai; Yaowen Chang; Chi Zhang; Guangxin Luan; Baodong Ling; Xu Jia
Journal:  Exp Ther Med       Date:  2016-10-20       Impact factor: 2.447

6.  Characterization of antibiotic-susceptibility patterns and virulence genes of five major sequence types of Escherichia coli isolates cultured from extraintestinal specimens: a 1-year surveillance study from Iran.

Authors:  Zoya Hojabri; Majid Mirmohammadkhani; Narges Darabi; Maedeh Arab; Omid Pajand
Journal:  Infect Drug Resist       Date:  2019-04-17       Impact factor: 4.003

7.  Clonal diversity, virulence genes content and subclone status of Escherichia coli sequence type 131: comparative analysis of E. coli ST131 and non-ST131 isolates from Iran.

Authors:  Zoya Hojabri; Narges Darabi; Maedeh Arab; Fereshteh Saffari; Omid Pajand
Journal:  BMC Microbiol       Date:  2019-05-30       Impact factor: 3.605

8.  Molecular survey of aminoglycoside-resistant Acinetobacter baumannii isolated from tertiary hospitals in Qazvin, Iran.

Authors:  P Rashvand; A Peymani; M Mohammadi; A A Karami; R Samimi; S Hajian; D Porasgari; N Habibollah-Pourzereshki
Journal:  New Microbes New Infect       Date:  2021-04-23

9.  Increasing frequency of Aminoglycoside-Resistant Klebsiella pneumoniae during the era of pandemic COVID-19.

Authors:  Omar B Ahmed; Atif H Asghar; Fayez S Bahwerth
Journal:  Mater Today Proc       Date:  2021-05-21

10.  The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains.

Authors:  Wioletta Adamus-Białek; Anna Baraniak; Monika Wawszczak; Stanisław Głuszek; Beata Gad; Klaudia Wróbel; Paulina Bator; Marta Majchrzak; Paweł Parniewski
Journal:  Mol Biol Rep       Date:  2018-07-14       Impact factor: 2.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.